Fenofibrate

Fenofibrate

SCHEMBL6901888

CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O.CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARA

The experimentally established mechanism targets of Fenofibrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA known ✓ Q07869 8/20 0.69
PPARG P37231 5/20 0.69
LMNA P02545 3/20 0.69
TSHR P16473 3/20 0.69
MEN1 O00255 3/20 0.69
KMT2A Q03164 3/20 0.69
CYP1A2 P05177 3/20 0.69
CYP3A4 P08684 3/20 0.69
CYP2C9 P11712 2/20 0.69
BLM P54132 2/20 0.69
MAPT P10636 2/20 0.69
CYP2C19 P33261 2/20 0.69
SMN1; SMN2 Q16637 2/20 0.69
ABCB11 O95342 2/20 0.69
HTR2A P28223 2/20 0.69
PMP22 Q01453 2/20 0.69
USP2 O75604 1/20 0.69
ADORA3 P0DMS8 1/20 0.69
ADRB3 P13945 1/20 0.69
HPGD P15428 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fenofibrate SCHEMBL3876232 0.83 PPARA (1.00) PPARAPPARGLMNATSHRMEN1
Fenofibrate SCHEMBL4670 0.83 PPARA (1.00) PPARAPPARGLMNATSHRMEN1
Fenofibrate SCHEMBL27847067 0.82 PPARA (0.97) PPARAPPARGLMNATSHRMEN1
Fenofibrate SCHEMBL22209064 0.82 PPARA (0.97) PPARAPPARGLMNATSHRMEN1
Fenofibrate SCHEMBL29262793 0.82 PPARA (0.97) PPARAPPARGLMNATSHRMEN1
Fenofibrate SCHEMBL29262792 0.82 PPARA (0.97) PPARAPPARGLMNATSHRMEN1
Fenofibrate SCHEMBL21758490 0.82 PPARA (0.97) PPARAPPARGLMNATSHRMEN1
Ciprofibrate SCHEMBL26870 0.80 PPARA (1.00) PPARAPPARGLMNATSHRMEN1
Ciprofibrate SCHEMBL8164529 0.80 PPARA (1.00) PPARAPPARGLMNATSHRMEN1
SCHEMBL31084127 0.80 PPARA (0.92) PPARAPPARGLMNATSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1019059-A4 USE OF FXR, PPARalpha AND LXRalpha ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION UNIV CALIFORNIA (US) 2004-01-14 EP disclosed
WO-2000049992-A2 USE OF FXR, PPARα AND LXRα ACTIVATORS TO TREAT ACNE/ACNEIFORM CONDITIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2000-08-31 WO disclosed
EP-1019059-A1 USE OF FXR, PPARalpha AND LXRalpha ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2000-07-19 EP disclosed
WO-1998032444-A1 USE OF FXR, PPARα AND LXRα ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1998-07-30 WO disclosed